Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

被引:0
作者
Rachel L. O’Connell
Bhupinder Sharma
Dima El-Sharkawi
Andrew Wotherspoon
Ayoma D. Attygalle
Fiona MacNeill
Aadil A. Khan
Marios-Konstantinos Tasoulis
机构
[1] The Royal Marsden NHS Foundation Trust,Breast Surgery Unit
[2] The Institute of Cancer Research,Department of Radiology
[3] The Royal Marsden NHS Foundation Trust,Heamato
[4] The Royal Marsden NHS Foundation Trust,oncology Unit
[5] The Royal Marsden NHS Foundation Trust,Plastic Surgery Unit
[6] Hisopathology Unit,undefined
[7] The Royal Marsden NHS Foundation Trust,undefined
来源
Annals of Surgical Oncology | 2023年 / 30卷
关键词
Breast implants; Lymphoma; Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL); Non-Hodgkin lymphoma; Capsulectomy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:6170 / 6175
页数:5
相关论文
共 50 条
  • [41] UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG)
    Turton, Philip
    El-Sharkawi, Dima
    Lyburn, Iain
    Sharma, Bhupinder
    Mahalingam, Preethika
    Turner, Suzanne D.
    MacNeill, Fiona
    Johnson, Laura
    Hamilton, Stephen
    Burton, Cathy
    Mercer, Nigel
    EJSO, 2021, 47 (02): : 199 - 210
  • [42] The flow cytometric characteristics of breast implant-associated anaplastic large cell lymphoma
    Barr, Jordan
    Campbell, Heather
    McGuire, Lloyd
    Cochrane, Tara
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (02) : E121 - E123
  • [43] The management of breast implant-associated anaplastic large cell lymphoma in the setting of pregnancy: seeking for clinical practice guidelines
    Elia, Rossella
    Maruccia, Michele
    De Pascale, Aurelia
    Di Napoli, Arianna
    Ingravallo, Giuseppe
    Giudice, Giuseppe
    ARCHIVES OF PLASTIC SURGERY-APS, 2021, 48 (04): : 373 - 377
  • [44] European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey
    Inés Villarroya-Marquina
    Shawn Moshrefi
    Clifford Sheckter
    Gordon K. Lee
    Aesthetic Plastic Surgery, 2020, 44 : 1387 - 1395
  • [45] European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey
    Villarroya-Marquina, Ines
    Moshrefi, Shawn
    Sheckter, Clifford
    Lee, Gordon K.
    AESTHETIC PLASTIC SURGERY, 2020, 44 (05) : 1387 - 1395
  • [46] Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology
    Julien, Louis-Andre
    Michel, Rene P.
    Auger, Manon
    CANCER CYTOPATHOLOGY, 2020, 128 (07) : 440 - 451
  • [47] Breast Implant-associated Anaplastic Large Cell Lymphoma An Evidence-based Systematic Review
    DeCoster, Ryan C.
    Lynch, Evan B.
    Bonaroti, Alisha R.
    Webster, John Matthew
    Butterfield, Timothy A.
    Evers, Bernard Mark
    Vasconez, Henry C.
    Clemens, Mark W.
    ANNALS OF SURGERY, 2021, 273 (03) : 449 - 458
  • [48] Coming of Age Breast Implant-Associated Anaplastic Large Cell Lymphoma After 18 Years of Investigation
    Clemens, Mark W.
    Miranda, Roberto N.
    CLINICS IN PLASTIC SURGERY, 2015, 42 (04) : 605 - +
  • [49] Current status of breast implant-associated anaplastic large cell lymphoma in South Korea
    Yoon, Eul-Sik
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (01): : 5 - 9
  • [50] Brentuximab vedotin as monotherapy for unresectable breast implant-associated anaplastic large cell lymphoma
    Stack, Anthony
    Levy, Isaac
    CLINICAL CASE REPORTS, 2019, 7 (05): : 1003 - 1006